切换导航
  • 比较产品
我的购物车

若您需要咨询产品或有任何技术问题，请通过官方电话 400 885 9050 或邮箱 info.cn@stemcell.com 与我们联系

EasySep™人Naïve CD8+ T细胞分选试剂盒

人Naïve CD8+ T细胞的免疫磁珠负选
率先评论此产品
添加并比较

产品号 #（选择产品）

产品号 #19258_C

人Naïve CD8+ T细胞的免疫磁珠负选

产品优势

  • 操作简单、快捷，且无需分离柱
  • 纯度高达97%
  • 获得的活细胞无标记

产品组分包括

  • EasySep™人 Naïve CD8+ T细胞分选试剂盒（产品号 #19258）
    • EasySep™人Naïve CD8+ T细胞分选抗体混合物，1 mL
    • EasySep™ D2 Magnetic Particles磁珠，2 x 1 mL
  • RoboSep™人Naïve CD8+ T细胞分选试剂盒（产品号 #19258RF）
    • EasySep™人Naïve CD8+ T细胞分选抗体混合物，1 mL
    • EasySep™ D2 Magnetic Particles磁珠，5 x 1 mL
    • RoboSep™ 缓冲液（产品号 #20104）
    • RoboSep™过滤吸头（产品号 #20125）x 2
main product photo
New look, same high quality and support! You may notice that your instrument or reagent packaging looks slightly different from images displayed on the website, or from previous orders. We are updating our look but rest assured, the products themselves and how you should use them have not changed. Learn more
专为您的实验方案打造的产品
要查看实验方案所需的所有配套产品，请参阅《实验方案与技术文档》。
  1. EasySep™ Magnet
    EasySep™ Magnet

    Magnet for column-free immunomagnetic separation

  2. EasySep™ Buffer
    EasySep™ Buffer

    Cell separation buffer

总览
实验数据
产品说明书及文档
应用领域
相关材料与文献
相关产品

总览

使用EasySep™人Naïve CD8+ T细胞分选试剂盒，可轻松高效地通过免疫磁珠负选从人新鲜外周血单个核细胞（PBMC）样本中分离高纯度的人初始CD8+ T细胞（CD8+CD45RA+CCR7+且CD45RO-CD57-CD56-）。EasySep™结合了单克隆抗体的特异性和无柱磁性系统的简便性，迄今已广泛应用于发表的研究中超过20年。

在此 EasySep™负选过程中，表达以下标记物的非目标细胞通过抗体复合物和磁珠标记被靶向去除：CD4、CD14、CD16、CD19、CD20、CD36、CD45RO、CD56、CD57、CD94、CD123、CD244、TCRγ/δ和Gly A。随后使用EasySep™磁极将磁珠标记的细胞与未标记的目标初始CD8+ T细胞分离，只需将目的细胞直接倾倒或吸取至新的离心管中即可。磁珠分选获得的目的初始CD8+ T细胞可直接用于流式细胞术、细胞培养或DNA/RNA提取等下游应用。

如需更快速的细胞分选方案，我们推荐EasySep™人Naïve  CD8+ T细胞分选试剂盒 II（17968），其分选过程仅需11分钟。

了解更多关于免疫磁珠EasySep™技术的工作原理，或如何通过RoboSep™实现全自动化免疫磁珠细胞分选 。探索更多优化您实验流程的产品，包括培养基、添加剂、抗体等。

在此 EasySep™负选过程中，表达以下标记物的非目标细胞通过抗体复合物和磁珠标记被靶向去除：CD4、CD14、CD16、CD19、CD20、CD36、CD45RO、CD56、CD57、CD94、CD123、CD244、TCRγ/δ和Gly A。随后使用EasySep™磁极将磁珠标记的细胞与未标记的目标初始CD8+ T细胞分离，只需将目的细胞直接倾倒或吸取至新的离心管中即可。磁珠分选获得的目的初始CD8+ T细胞可直接用于流式细胞术、细胞培养或DNA/RNA提取等下游应用。

如需更快速的细胞分选方案，我们推荐EasySep™人Naïve  CD8+ T细胞分选试剂盒 II（17968），其分选过程仅需11分钟。

了解更多关于免疫磁珠EasySep™技术的工作原理，或如何通过RoboSep™实现全自动化免疫磁珠细胞分选 。探索更多优化您实验流程的产品，包括培养基、添加剂、抗体等。

在此 EasySep™负选过程中，表达以下标记物的非目标细胞通过抗体复合物和磁珠标记被靶向去除：CD4、CD14、CD16、CD19、CD20、CD36、CD45RO、CD56、CD57、CD94、CD123、CD244、TCRγ/δ和Gly A。随后使用EasySep™磁极将磁珠标记的细胞与未标记的目标初始CD8+ T细胞分离，只需将目的细胞直接倾倒或吸取至新的离心管中即可。磁珠分选获得的目的初始CD8+ T细胞可直接用于流式细胞术、细胞培养或DNA/RNA提取等下游应用。

如需更快速的细胞分选方案，我们推荐EasySep™人Naïve  CD8+ T细胞分选试剂盒 II（17968），其分选过程仅需11分钟。

了解更多关于免疫磁珠EasySep™技术的工作原理，或如何通过RoboSep™实现全自动化免疫磁珠细胞分选 。探索更多优化您实验流程的产品，包括培养基、添加剂、抗体等。

在此 EasySep™负选过程中，表达以下标记物的非目标细胞通过抗体复合物和磁珠标记被靶向去除：CD4、CD14、CD16、CD19、CD20、CD36、CD45RO、CD56、CD57、CD94、CD123、CD244、TCRγ/δ和Gly A。随后使用EasySep™磁极将磁珠标记的细胞与未标记的目标初始CD8+ T细胞分离，只需将目的细胞直接倾倒或吸取至新的离心管中即可。磁珠分选获得的目的初始CD8+ T细胞可直接用于流式细胞术、细胞培养或DNA/RNA提取等下游应用。

如需更快速的细胞分选方案，我们推荐EasySep™人Naïve  CD8+ T细胞分选试剂盒 II（17968），其分选过程仅需11分钟。

了解更多关于免疫磁珠EasySep™技术的工作原理，或如何通过RoboSep™实现全自动化免疫磁珠细胞分选 。探索更多优化您实验流程的产品，包括培养基、添加剂、抗体等。

磁体兼容性
• EasySep™ Magnet (Catalog #18000) • “The Big Easy” EasySep™ Magnet (Catalog #18001) • RoboSep™-S (Catalog #21000)
 
亚型
细胞分选试剂盒
 
细胞类型
T 细胞，T 细胞，CD8+
 
种属
人
 
样本来源
PBMC
 
筛选方法
Negative
 
应用
细胞分选
 
品牌
EasySep，RoboSep
 
研究领域
免疫
 

查看更多 显示更少

实验数据

Typical EasySep™ Human Naïve CD8+ T Cell Isolation Profile

Figure 1. Typical EasySep™ Human Naïve CD8+ T Cell Isolation Profile

Starting with fresh PBMCs, the naïve CD8+ T cell content (CD8+CD45RA+CCR7+ and CD45RO-CD57-CD56-) of the isolated fraction is typically 92.3 ± 4.0% (mean ± SD) using the purple EasySep™ Magnet. In the above example, the purities of the start and final isolated fractions are 3.9% and 92.8%, respectively.

产品说明书及文档

请在《产品说明书》中查找相关支持信息和使用说明，或浏览下方更多实验方案。

Document Type
Product Name
Catalog #
Lot #
Language
Document Type
Product Information Sheet
Product Name
EasySep™ Human Naïve CD8+ T Cell Isolation Kit
Catalog #
19258
Lot #
All
Language
English
Document Type
Product Information Sheet
Product Name
RoboSep™ Human Naive CD8+ T Cell Isolation Kit
Catalog #
19258RF
Lot #
All
Language
English
Document Type
Safety Data Sheet 1
Product Name
EasySep™ Human Naïve CD8+ T Cell Isolation Kit
Catalog #
19258
Lot #
All
Language
English
Document Type
Safety Data Sheet 2
Product Name
EasySep™ Human Naïve CD8+ T Cell Isolation Kit
Catalog #
19258
Lot #
All
Language
English
Document Type
Safety Data Sheet 1
Product Name
RoboSep™ Human Naive CD8+ T Cell Isolation Kit
Catalog #
19258RF
Lot #
All
Language
English
Document Type
Safety Data Sheet 2
Product Name
RoboSep™ Human Naive CD8+ T Cell Isolation Kit
Catalog #
19258RF
Lot #
All
Language
English
Document Type
Safety Data Sheet 3
Product Name
RoboSep™ Human Naive CD8+ T Cell Isolation Kit
Catalog #
19258RF
Lot #
All
Language
English

应用领域

本产品专为以下研究领域设计，适用于工作流程中的高亮阶段。探索这些工作流程，了解更多我们为各研究领域提供的其他配套产品。

Research Area
Workflow Stages

相关材料与文献

技术资料 (2)

EasySep™ Cell Separation Technology
Brochure
EasySep™ Cell Separation Technology
Human Immune Cytokines
Wallchart
Human Immune Cytokines

文献 (4)

Comparative analysis of the DNA methylation landscape in CD4, CD8, and B memory lineages. Z. Zhang et al. Clinical epigenetics 2022 dec

Abstract

BACKGROUND There is considerable evidence that epigenetic mechanisms and DNA methylation are critical drivers of immune cell lineage differentiation and activation. However, there has been limited coordinated investigation of common epigenetic pathways among cell lineages. Further, it remains unclear if long-lived memory cell subtypes differentiate distinctly by cell lineages. RESULTS We used the Illumina EPIC array to investigate the consistency of DNA methylation in B cell, CD4 T, and CD8 T na{\{i}}ve and memory cells states. In the process of na{\"{i}}ve to memory activation across the three lineages we identify considerable shared epigenetic regulation at the DNA level for immune memory generation. Further in central to effector memory differentiation our analyses revealed specific CpG dinucleotides and genes in CD4 T and CD8 T cells with DNA methylation changes. Finally we identified unique DNA methylation patterns in terminally differentiated effector memory (TEMRA) CD8 T cells compared to other CD8 T memory cell subtypes. CONCLUSIONS Our data suggest that epigenetic alterations are widespread and essential in generating human lymphocyte memory. Unique profiles are involved in methylation changes that accompany memory genesis in the three subtypes of lymphocytes."
View publication
IL-9/STAT3/fatty acid oxidation-mediated lipid peroxidation contributes to Tc9 cell longevity and enhanced antitumor activity. L. Xiao et al. The Journal of clinical investigation 2022 apr

Abstract

CD8+ T cell longevity regulated by metabolic activity plays important roles in cancer immunotherapy. Although in vitro-polarized, transferred IL-9-secreting CD8+ Tc9 (cytotoxic T lymphocyte subset 9) cells exert greater persistence and antitumor efficacy than Tc1 cells, the underlying mechanism remains unclear. Here, we show that tumor-infiltrating Tc9 cells display significantly lower lipid peroxidation than Tc1 cells in several mouse models, which is strongly correlated with their persistence. Using RNA-sequence and functional validation, we found that Tc9 cells exhibited unique lipid metabolic programs. Tc9 cell-derived IL-9 activated STAT3, upregulated fatty acid oxidation and mitochondrial activity, and rendered Tc9 cells with reduced lipid peroxidation and resistance to tumor- or ROS-induced ferroptosis in the tumor microenvironment. IL-9 signaling deficiency, inhibiting STAT3, or fatty acid oxidation increased lipid peroxidation and ferroptosis of Tc9 cells, resulting in impaired longevity and antitumor ability. Similarly, human Tc9 cells also exhibited lower lipid peroxidation than Tc1 cells and tumor-infiltrating CD8+ T cells expressed lower IL9 and higher lipid peroxidation- and ferroptosis-related genes than circulating CD8+ T cells in patients with melanoma. This study indicates that lipid peroxidation regulates Tc9 cell longevity and antitumor effects via the IL-9/STAT3/fatty acid oxidation pathway and regulating T cell lipid peroxidation can be used to enhance T cell-based immunotherapy in human cancer.
View publication
Age-Associated Changes to Lymph Node Fibroblastic Reticular Cells. T. Kwok et al. Frontiers in aging 2022

Abstract

The decreased proportion of antigen-inexperienced, na{\{i}}ve T cells is a hallmark of aging in both humans and mice and contributes to reduced immune responses particularly against novel and re-emerging pathogens. Na{\"{i}}ve T cells depend on survival signals received during their circulation among the lymph nodes by direct contacts with stroma in particular fibroblastic reticular cells. Macroscopic changes to the architecture of the lymph nodes have been described but it is unclear how lymph node stroma are altered with age and whether these changes contribute to reduced na{\"{i}}ve T cell maintenance. Here using 2-photon microscopy we determined that the aged lymph node displayed increased fibrosis and correspondingly that na{\"{i}}ve T-cell motility was impaired in the aged lymph node especially in proximity to fibrotic deposition. Functionally adoptively transferred young na{\"{i}}ve T-cells exhibited reduced homeostatic turnover in aged hosts supporting the role of T cell-extrinsic mechanisms that regulate their survival. Further we determined that early development of resident fibroblastic reticular cells was impaired which may correlate to the declining levels of na{\"{i}}ve T-cell homeostatic factors observed in aged lymph nodes. Thus our study addresses the controversy as to whether aging impacts the composition lymph node stroma and supports a model in which impaired differentiation of lymph node fibroblasts and increased fibrosis inhibits the interactions necessary for na{\"{i}}ve T cell homeostasis."
View publication
View All Publications

更多信息

更多信息
种属 Human
Magnet Compatibility • EasySep™ Magnet (Catalog #18000) • “The Big Easy” EasySep™ Magnet (Catalog #18001) • RoboSep™-S (Catalog #21000)
样本来源 PBMC
Selection Method Negative
标记抗体
  1. 抗人CD45RO抗体，克隆UCHL1
    抗人CD45RO抗体，克隆UCHL1

    小鼠单克隆IgG2a抗体，抗人、黑猩猩、普通狨猴CD45RO

  2. 抗人CD56抗体，克隆HCD56
    抗人CD56抗体，克隆HCD56

    小鼠单克隆IgG1抗体，抗人CD56 （NCAM）

  3. 抗人CD8a抗体，克隆RPA-T8
    抗人CD8a抗体，克隆RPA-T8

    小鼠单克隆IgG1抗体，抗人、恒河猴、食蟹猴CD8a

质量保证:

产品仅供研究使用，不用于针对人或动物的诊断或治疗。 欲获悉更多关于STEMCELL的质控信息，请访问 STEMCELL.CN/COMPLIANCE.
Copyright © 2025 by STEMCELL Technologies. All rights reserved.